Representations of the (Lorentz) conformal group with the soft operators as highest weight vectors have two universal properties, which we clearly state in this paper. Given a soft operator with a certain dimension and spin, the first property is about the existence of "(large) gauge transformation" that acts on the soft operator. The second property is the decoupling of (large) gauge-invariant null-states of the soft operators from the S-matrix elements. In each case, the decoupling equation has the form of zero field-strength condition with the soft operator as the (gauge) potential. Null-state decoupling effectively reduces the number of polarisation states of the soft particle and is crucial in deriving soft-theorems from the Ward identities of asymptotic symmetries. To the best of our understanding, these properties are not directly related to the Lorentz invariance of the S-matrix or the existence of asymptotic symmetries. We also verify that the results obtained from the decoupling of null-states are consistent with the leading and subleading soft-theorems with finite energy massive and massless particles in the external legs.
In this paper we evaluate the modified celestial amplitude for gravitons and gluons, as defined in arXiv:1801.10171 [hep-th]. We find that the modified (tree) amplitude is finite for gravitons in Einstein gravity. The modified amplitude behaves like correlation function of operators inserted at various points of null-infinity in the Minkowski space-time. Therefore, unlike the standard celestial amplitudes, these are three dimensional objects. We also show that this amplitude admits conformal soft factorization recently studied in the literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.